336 results on '"Pratt, Victoria M."'
Search Results
2. The INGENIOUS trial: Impact of pharmacogenetic testing on adverse events in a pragmatic clinical trial
3. CYP3A4 and CYP3A5 Genotyping Recommendations: A Joint Consensus Recommendation of the Association for Molecular Pathology, Clinical Pharmacogenetics Implementation Consortium, College of American Pathologists, Dutch Pharmacogenetics Working Group of the Royal Dutch Pharmacists Association, European Society for Pharmacogenomics and Personalized Therapy, and Pharmacogenomics Knowledgebase
4. Pharmacogenetic testing in the Veterans Health Administration (VHA): policy recommendations from the VHA Clinical Pharmacogenetics Subcommittee
5. Design and rationale of GUARDD-US: A pragmatic, randomized trial of genetic testing for APOL1 and pharmacogenomic predictors of antihypertensive efficacy in patients with hypertension
6. Development of a Multifaceted Program for Pharmacogenetics Adoption at an Academic Medical Center: Practical Considerations and Lessons Learned.
7. Overcoming Barriers to Discovery and Implementation of Equitable Pharmacogenomic Testing in Oncology
8. 2024 Updates to American Medical Association's Current Procedural Terminology Codes for Oncology Panel Testing
9. DPYDGenotyping Recommendations
10. Implementing a pragmatic clinical trial to tailor opioids for chronic pain on behalf of the IGNITE ADOPT PGx investigators.
11. Expanding evidence leads to new pharmacogenomics payer coverage
12. Clinical Opportunities for Germline Pharmacogenetics and Management of Drug-Drug Interactions in Patients With Advanced Solid Cancers
13. Building Evidence for Clinical Use of Pharmacogenomics and Reimbursement for Testing
14. Multisite Investigation of Outcomes With Implementation of CYP2C19 Genotype-Guided Antiplatelet Therapy After Percutaneous Coronary Intervention
15. Opportunities to implement a sustainable genomic medicine program: lessons learned from the IGNITE Network
16. Lessons Learned When Introducing Pharmacogenomic Panel Testing into Clinical Practice
17. Translating pharmacogenetics from research to routine clinical practice – a survey of the IGNITE Network
18. Chapter 42 - Germline pharmacogenomics in cancer treatment
19. Correction: Opportunities to implement a sustainable genomic medicine program: lessons learned from the IGNITE Network
20. Analytical validity of a genotyping assay for use with personalized antihypertensive and chronic kidney disease therapy
21. Pharmacogenetics
22. Contributors
23. Building Evidence for Clinical Use of Pharmacogenomics and Reimbursement for Testing
24. Correction: Opportunities to implement a sustainable genomic medicine program: lessons learned from the IGNITE Network
25. Characterization of Reference Materials for TPMT and NUDT15
26. TPMT and NUDT15 Genotyping Recommendations: A Joint Consensus Recommendation of the Association for Molecular Pathology, Clinical Pharmacogenetics Implementation Consortium, College of American Pathologists, Dutch Pharmacogenetics Working Group of the Royal Dutch Pharmacists Association, European Society for Pharmacogenomics and Personalized Therapy, and Pharmacogenomics Knowledgebase
27. Response to Gammal et al.
28. List of Contributors
29. Allelic decomposition and exact genotyping of highly polymorphic and structurally variant genes
30. Abstract 1151: Pharmacogenomics genotyping from clinical somatic whole exome sequencing: Aldy, a computational tool
31. Analytical Validation of a Computational Method for Pharmacogenetic Genotyping from Clinical Whole Exome Sequencing
32. CYP2C8, CYP2C9, and CYP2C19 Characterization Using Next-Generation Sequencing and Haplotype Analysis: A GeT-RM Collaborative Project
33. Chapter 73: Pharmacogenetics
34. PharmVar GeneFocus:CYP3A5
35. Correction: Opportunities to implement a sustainable genomic medicine program: lessons learned from the IGNITE Network
36. CYP2C8, CYP2C9, and CYP2C19 Characterization Using Next-Generation Sequencing and Haplotype Analysis
37. Clinical pharmacogenomic testing and reporting: A technical standard of the American College of Medical Genetics and Genomics (ACMG)
38. PharmVar GeneFocus: CYP3A5
39. Pharmacogenomics of Hypertension in CKD: The CKD-PGX Study
40. Multisite investigation of strategies for the clinical implementation of pre-emptive pharmacogenetic testing
41. List of contributors
42. Characterization of 107 Genomic DNA Reference Materials for CYP2D6, CYP2C19, CYP2C9, VKORC1, and UGT1A1: A GeT-RM and Association for Molecular Pathology Collaborative Project
43. Recommendations for Clinical CYP2D6 Genotyping Allele Selection
44. FDAʼs draft guidance on laboratory-developed tests increases clinical and economic risk to adoption of pharmacogenetic testing
45. Development and Characterization of Reference Materials for MTHFR, SERPINA1, RET, BRCA1, and BRCA2 Genetic Testing
46. CpG Methylation Analysis—Current Status of Clinical Assays and Potential Applications in Molecular Diagnostics: A Report of the Association for Molecular Pathology
47. Identification of Cystic Fibrosis Variants by Polymerase Chain Reaction/Oligonucleotide Ligation Assay
48. Development of Genomic Reference Materials for Cystic Fibrosis Genetic Testing
49. Clinician Perspectives about Molecular Genetic Testing for Heritable Conditions and Development of a Clinician-Friendly Laboratory Report
50. CLINICAL OPPORTUNITIES FOR GERMLINE PHARMACOGENETICS AND MANAGEMENT OF DRUG-DRUG INTERACTIONS IN PATIENTS WITH ADVANCED SOLID CANCERS
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.